Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of LEPR mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of LEPR mRNA | affects expression | 21346803
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane affects the expression of LEPR mRNA | affects expression | 18648102
|
C014949 |
acetylhydrazine |
acetylhydrazine results in decreased expression of LEPR mRNA | decreases expression | 15282401
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of LEPR mRNA | affects expression | 16483693
|
D001151 |
Arsenic |
Arsenic results in decreased expression of LEPR mRNA | decreases expression | 19654921
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of AIFM1 mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of APP mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of CAT mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of CNTD1 mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of COX15 mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of COX5A mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of COX5B mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of COX6B1 mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of COX6C mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of FOXO3A mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of GNA13 mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of GPX3 mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of GRN mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of HMGB1 mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of HOXA9 mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of IDH1 mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of ND6 mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of NDUFA1 mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of NDUFA5 mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of NDUFC2 mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of NDUFV2 mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of NME2 mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of PPP1CB mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of PRDX1 mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of RPS2 mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of SOD1 mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of SPP1 mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of TGM2 mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of TKT mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of UBB mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of UQCRB mRNA] | decreases reaction|increases expression | 16964424
|
C005948 |
astaxanthine |
astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of UQCRC2 mRNA] | decreases reaction|increases expression | 16964424
|
D019324 |
beta-Naphthoflavone |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of LEPR mRNA | affects cotreatment|decreases expression | 18164116
|
D002118 |
Calcium |
Calcium affects the expression of LEPR mRNA | affects expression | 15913539
|
D002251 |
Carbon Tetrachloride |
Drugs, Chinese Herbal inhibits the reaction [[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of LEPR protein] | affects cotreatment|decreases reaction|increases expression | 18227024
|
D002857 |
Chromium |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of BTC mRNA] | affects binding|decreases expression|increases reaction | 16940432
|
D002857 |
Chromium |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of CIDEA mRNA] | affects binding|decreases expression|increases reaction | 16940432
|
D002857 |
Chromium |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of DDHD1 mRNA] | affects binding|decreases expression|increases reaction | 16940432
|
D002857 |
Chromium |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of NET1 mRNA] | affects binding|decreases expression|increases reaction | 16940432
|
D002857 |
Chromium |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of PCK1 mRNA] | affects binding|decreases expression|increases reaction | 16940432
|
D002857 |
Chromium |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of TTPA mRNA] | affects binding|decreases expression|increases reaction | 16940432
|
D002857 |
Chromium |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of UCP1 mRNA] | affects binding|decreases expression|increases reaction | 16940432
|
D002857 |
Chromium |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of ASPH mRNA] | affects binding|increases expression|increases reaction | 16940432
|
D002857 |
Chromium |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of CASQ1 mRNA] | affects binding|increases expression|increases reaction | 16940432
|
D002857 |
Chromium |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of EDNRB mRNA] | affects binding|increases expression|increases reaction | 16940432
|
D002857 |
Chromium |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of ENO3 mRNA] | affects binding|increases expression|increases reaction | 16940432
|
D002857 |
Chromium |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of GARNL1 mRNA] | affects binding|increases expression|increases reaction | 16940432
|
D002857 |
Chromium |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of GPI1 mRNA] | affects binding|increases expression|increases reaction | 16940432
|
D002857 |
Chromium |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of NRAP mRNA] | affects binding|increases expression|increases reaction | 16940432
|
D002857 |
Chromium |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of PI16 mRNA] | affects binding|increases expression|increases reaction | 16940432
|
D002857 |
Chromium |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of SRL mRNA] | affects binding|increases expression|increases reaction | 16940432
|
D002857 |
Chromium |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of TLN1 mRNA] | affects binding|increases expression|increases reaction | 16940432
|
D002857 |
Chromium |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of TPM1 mRNA] | affects binding|increases expression|increases reaction | 16940432
|
D002995 |
Clofibric Acid |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of LEPR mRNA | affects cotreatment|affects expression | 17602206
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of LEPR mRNA | decreases expression | 18721800
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of LEPR mRNA | affects cotreatment|decreases expression | 18164116
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of LEPR mRNA | affects cotreatment|affects expression | 17602206
|
D004280 |
Dobutamine |
LEPR protein affects the susceptibility to Dobutamine | affects response to substance | 20175764
|
D004365 |
Drugs, Chinese Herbal |
Drugs, Chinese Herbal inhibits the reaction [[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of LEPR protein] | affects cotreatment|decreases reaction|increases expression | 18227024
|
D004958 |
Estradiol |
Estradiol results in decreased expression of LEPR mRNA | decreases expression | 14664709
|
D004958 |
Estradiol |
LEPR protein affects the abundance of Estradiol | affects abundance | 15093691
|
D000431 |
Ethanol |
Drugs, Chinese Herbal inhibits the reaction [[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of LEPR protein] | affects cotreatment|decreases reaction|increases expression | 18227024
|
D000431 |
Ethanol |
Ethanol results in decreased expression of LEPR mRNA | decreases expression | 16098508
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of LEPR mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LEPR mRNA | affects cotreatment|increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of LEPR mRNA | decreases expression | 17351261
|
D005038 |
Ethylnitrosourea |
Ethylnitrosourea results in increased mutagenesis of LEPR gene | increases mutagenesis | 16724327
|
D015525 |
Fatty Acids, Omega-3 |
Fatty Acids, Omega-3 results in increased expression of LEPR mRNA | increases expression | 15949695
|
C419708 |
gefitinib |
gefitinib results in decreased expression of LEPR mRNA | decreases expression | 16685379
|
C029424 |
hydrazine |
hydrazine results in increased expression of LEPR mRNA | increases expression | 15370871
|
D007657 |
Ketone Bodies |
Ketone Bodies results in decreased expression of LEPR mRNA | decreases expression | 16807920
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides inhibits the reaction [Thioacetamide results in decreased expression of LEPR mRNA] | decreases expression|decreases reaction | 17621560
|
D008628 |
Mercury |
Mercury results in decreased expression of LEPR mRNA | decreases expression | 16823088
|
D009020 |
Morphine |
Morphine results in increased expression of LEPR mRNA | increases expression | 20144693
|
D009525 |
Niacin |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of BTC mRNA] | affects binding|decreases expression|increases reaction | 16940432
|
D009525 |
Niacin |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of CIDEA mRNA] | affects binding|decreases expression|increases reaction | 16940432
|
D009525 |
Niacin |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of DDHD1 mRNA] | affects binding|decreases expression|increases reaction | 16940432
|
D009525 |
Niacin |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of NET1 mRNA] | affects binding|decreases expression|increases reaction | 16940432
|
D009525 |
Niacin |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of PCK1 mRNA] | affects binding|decreases expression|increases reaction | 16940432
|
D009525 |
Niacin |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of TTPA mRNA] | affects binding|decreases expression|increases reaction | 16940432
|
D009525 |
Niacin |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of UCP1 mRNA] | affects binding|decreases expression|increases reaction | 16940432
|
D009525 |
Niacin |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of ASPH mRNA] | affects binding|increases expression|increases reaction | 16940432
|
D009525 |
Niacin |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of CASQ1 mRNA] | affects binding|increases expression|increases reaction | 16940432
|
D009525 |
Niacin |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of EDNRB mRNA] | affects binding|increases expression|increases reaction | 16940432
|
D009525 |
Niacin |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of ENO3 mRNA] | affects binding|increases expression|increases reaction | 16940432
|
D009525 |
Niacin |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of GARNL1 mRNA] | affects binding|increases expression|increases reaction | 16940432
|
D009525 |
Niacin |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of GPI1 mRNA] | affects binding|increases expression|increases reaction | 16940432
|
D009525 |
Niacin |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of NRAP mRNA] | affects binding|increases expression|increases reaction | 16940432
|
D009525 |
Niacin |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of PI16 mRNA] | affects binding|increases expression|increases reaction | 16940432
|
D009525 |
Niacin |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of SRL mRNA] | affects binding|increases expression|increases reaction | 16940432
|
D009525 |
Niacin |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of TLN1 mRNA] | affects binding|increases expression|increases reaction | 16940432
|
D009525 |
Niacin |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of TPM1 mRNA] | affects binding|increases expression|increases reaction | 16940432
|
C042763 |
olive oil |
olive oil analog affects the expression of LEPR mRNA | affects expression | 17349074
|
D010126 |
Ozone |
LEPR gene mutant form promotes the reaction [Ozone results in increased expression of CCL11 protein] | increases expression|increases reaction | 16373670
|
D010126 |
Ozone |
LEPR gene mutant form promotes the reaction [Ozone results in increased expression of CXCL1 protein] | increases expression|increases reaction | 16373670
|
D010126 |
Ozone |
LEPR gene mutant form promotes the reaction [Ozone results in increased expression of CXCL2 protein] | increases expression|increases reaction | 16373670
|
D010126 |
Ozone |
LEPR gene mutant form promotes the reaction [Ozone results in increased expression of IL6 protein] | increases expression|increases reaction | 16373670
|
D010126 |
Ozone |
LEPR gene mutant form results in increased susceptibility to Ozone | increases response to substance | 16373670
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in increased expression of LEPR mRNA | increases expression | 17681415
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of LEPR mRNA | affects binding|increases activity|increases expression | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of LEPR mRNA | increases expression | 18301758 18445702
|
D013619 |
Tacrine |
Tacrine results in increased expression of LEPR mRNA | increases expression | 12832660
|
D013739 |
Testosterone |
LEPR protein affects the abundance of Testosterone | affects abundance | 15093691
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of LEPR mRNA | increases expression | 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LEPR mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin affects the expression of LEPR mRNA | affects expression | 15977195
|
D013853 |
Thioacetamide |
Thioacetamide results in increased expression of LEPR mRNA | increases expression | 17997003
|
D013853 |
Thioacetamide |
LEPR gene mutant form inhibits the reaction [Thioacetamide results in increased expression of TGFB1 mRNA] | decreases reaction|increases expression | 11984526
|
D013853 |
Thioacetamide |
LEPR protein affects the reaction [Thioacetamide results in increased expression of TGFB1 mRNA] | affects reaction|increases expression | 11984526
|
D013853 |
Thioacetamide |
Lipopolysaccharides inhibits the reaction [Thioacetamide results in decreased expression of LEPR mRNA] | decreases expression|decreases reaction | 17621560
|
D013853 |
Thioacetamide |
Thioacetamide results in decreased expression of LEPR mRNA | decreases expression | 17621560
|
D013853 |
Thioacetamide |
Thioacetamide results in decreased expression of LEPR protein | decreases expression | 17621560
|
D019772 |
Topotecan |
LEPR protein affects the susceptibility to Topotecan | affects response to substance | 16217747
|
D015054 |
Zymosan |
LEPR protein affects the susceptibility to Zymosan | affects response to substance | 15142272
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
7.17 | 17676605 18926900 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.17 | 14514962 15322242 11752688 |
MESH:D000038 |
Abscess |
|
Drugs, Chinese Herbal |
5.91 | 15043669 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
9.16 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
9.16 | 11192467 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.54 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
7.84 | 18653653 11850527 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
7.84 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
3.85 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
3.85 | 14692618 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
14.10 | 3712494 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
14.10 | 19389873 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
14.10 | 6695378 10737359 |
MESH:D000236 |
Adenoma |
|
Ethylnitrosourea |
14.10 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
14.99 | 16434500 17620307 18056438 19052882 17162532 19061943 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
14.99 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
14.99 | 16835633 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
4.81 | 17306315 |
MESH:D000419 |
Albuminuria |
marker/mechanism |
|
| 20175764 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
4.92 | 15451039 15451040 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
4.54 | 15513908 |
MESH:D000544 |
Alzheimer Disease |
|
Tacrine |
4.54 | 12725862 |
MESH:D000740 |
Anemia |
|
Drugs, Chinese Herbal |
13.08 | 15504547 17963324 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
13.08 | 11748828 |
MESH:D000740 |
Anemia |
|
Zymosan |
13.08 | 18664788 |
MESH:D000787 |
Angina Pectoris |
|
Drugs, Chinese Herbal |
5.02 | 11477813 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.43 | 15513904 |
MESH:D000987 |
Antisocial Personality Disorder |
|
Testosterone |
5.45 | 7506515 |
MESH:D001004 |
Anus Diseases |
|
Drugs, Chinese Herbal |
5.56 | 15043669 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
3.70 | 11141031 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.75 | 12569548 16251483 16835338 18414634 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
8.63 | 15238619 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
8.63 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
6.77 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Zymosan |
6.77 | 16872482 17659584 15142272 15188379 15944321 |
MESH:D015210 |
Arthritis, Gouty |
|
Drugs, Chinese Herbal |
5.36 | 19655406 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.46 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
2.51 | 17854713 16373670 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
6.49 | 12928151 19371607 |
MESH:D050197 |
Atherosclerosis |
|
olive oil |
6.49 | 16216721 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Fatty Acids, Omega-3 |
4.55 | 18448859 |
MESH:D001321 |
Autistic Disorder |
|
Fatty Acids, Omega-3 |
2.90 | 16920077 |
MESH:D001321 |
Autistic Disorder |
|
Mercury |
2.90 | 17497416 |
MESH:D001327 |
Autoimmune Diseases |
|
Mercury |
4.49 | 16634805 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.62 | 11289319 1440618 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
13.31 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
13.31 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Thioacetamide |
13.31 | 19483382 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.39 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.51 | 15746008 |
MESH:D001862 |
Bone Resorption |
|
Drugs, Chinese Herbal |
4.47 | 9881647 |
MESH:D001927 |
Brain Diseases |
|
Ethylnitrosourea |
4.54 | 14991843 |
MESH:D002545 |
Brain Ischemia |
|
Morphine |
4.75 | 19211983 |
MESH:D001932 |
Brain Neoplasms |
|
Ethylnitrosourea |
3.95 | 16651633 15144691 16436596 16357521 18412241 |
MESH:D001943 |
Breast Neoplasms |
|
Chromium |
2.75 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.75 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.75 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.75 | 17261762 16675129 17289903 18497071 12948864 19861407 14630087 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
Testosterone |
2.75 | 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.75 | 20435547 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.37 | 16777450 19059883 18315731 14754758 15516495 17626835 18417511 |
MESH:D002056 |
Burns |
|
Ethanol |
4.27 | 16374292 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.35 | 16183385 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.07 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.40 | 10355542 16227642 16097048 15700767 18705752 15721981 16124888 15673190 16011737 3786805 16050911 16192424 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.49 | 16835633 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.36 | 17687452 15504454 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
18.41 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
18.41 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
18.41 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
18.41 | 16507464 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
18.41 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
18.41 | 16779866 16878318 19822196 18393292 18971187 16935385 17978847 16288022 20007298 18506893 21159647 20101231 20935162 18210153 16830150 19208518 19171122 16328049 17428255 17173139 11831363 19701751 18056438 17761372 17138121 20214788 16540662 17162532 19418558 16569478 16807293 19919837 19539802 19107877 20524982 16502159 18691550 20512989 10737359 18494052 18785209 20514400 20432363 17055752 20084675 19383236 18665156 3084413 19335982 20727157 19394651 19052882 3581430 10672840 16698587 18788625 19519916 18978308 16681979 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
18.41 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
18.41 | 15289165 15763234 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Thioacetamide |
18.41 | 17997003 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
gefitinib |
3.81 | 16230376 20005069 19233551 15496427 17290066 18347146 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.48 | 7296757 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
2.57 | 18922899 17687452 15504454 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
3.74 | 18640142 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
6.10 | 19332462 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.10 | 16120746 18670907 18850075 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Mercury |
3.31 | 10334427 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
7.05 | 15738583 17938729 19152805 |
MESH:D002318 |
Cardiovascular Diseases |
|
olive oil |
7.05 | 16216721 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
3.98 | 16973168 18022660 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
18.21 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
18.21 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
18.21 | 7505956 21159647 2727394 17174075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
18.21 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Ethylnitrosourea |
18.21 | 16003739 |
MESH:D016543 |
Central Nervous System Neoplasms |
|
Ethylnitrosourea |
5.58 | 17160924 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Testosterone |
3.53 | 20678186 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
14.21 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
14.21 | 16835633 |
MESH:D018281 |
Cholangiocarcinoma |
|
Thioacetamide |
14.21 | 18291259 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
11.68 | 9022650 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
11.68 | 17333356 16105132 15861022 17681005 11677210 16919318 17110522 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
11.68 | 19176532 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
3.37 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
5.37 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.37 | 15668235 15340226 12621046 8697196 16354765 |
MESH:D015179 |
Colorectal Neoplasms |
|
gefitinib |
3.24 | 17594712 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.73 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
2.50 | 15451039 10194807 19302082 15451040 11873399 15513904 11198716 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.50 | 20055451 15322242 10048152 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
9.61 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
9.61 | 18551238 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
5.94 | 11298694 8156756 11906362 12868966 8970840 18759878 2524372 14531868 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Mercury |
5.94 | 16823706 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.24 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.13 | 2952479 3621924 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
marker/mechanism |
|
| 15093691 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
marker/mechanism |
|
| 20175764 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
astaxanthine |
6.66 | 16964424 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
6.66 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.66 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.08 | 19279558 |
MESH:D003967 |
Diarrhea |
|
Morphine |
4.16 | 2540324 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
23.33 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
23.33 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
23.33 | 9653073 9328219 7440962 18692083 6482804 18289764 8291058 1440618 16192314 11289319 18648102 9022650 6679447 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
23.33 | 6884620 10915739 19085960 9327722 16177239 4309450 15027814 21278145 10092053 2869522 19336974 15968718 3786805 17522070 7120509 16227642 3732212 7440962 7179309 15998439 11566570 6623471 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
23.33 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Drugs, Chinese Herbal |
23.33 | 15027814 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
23.33 | 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
23.33 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Thioacetamide |
23.33 | 12963478 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.47 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.17 | 18367378 |
MESH:D004476 |
Ectodermal Dysplasia |
|
Ethylnitrosourea |
5.58 | 18357618 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
13.63 | 17259670 12083418 |
MESH:D004487 |
Edema |
|
pirinixic acid |
13.63 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
13.63 | 12711302 11000095 |
MESH:D004487 |
Edema |
|
Zymosan |
13.63 | 7907874 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.50 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
2.82 | 12538720 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
2.72 | 11473722 18566989 19148513 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.68 | 9294722 10568697 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.00 | 15821434 17637181 15328337 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.71 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
4.26 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
4.26 | 16704527 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.72 | 11564622 |
MESH:D005218 |
Fat Necrosis |
|
Thioacetamide |
5.32 | 16456712 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
26.16 | 15959796 19224547 12631006 17595544 12795759 16239168 61145 16045604 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
26.16 | 18296743 17967931 19004024 19551842 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
26.16 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
26.16 | 16409862 18620774 19236843 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
26.16 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
26.16 | 20131406 19236843 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
5.26 | 17920746 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
4.90 | 15451040 16946407 15513904 10194807 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.07 | 11858732 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.67 | 9205823 11852909 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.62 | 6705139 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
12.54 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
12.54 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
12.54 | 20067830 |
MESH:D005391 |
Firesetting Behavior |
|
Testosterone |
5.45 | 7506515 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.16 | 6392382 |
MESH:D005756 |
Gastritis |
|
Ethanol |
4.29 | 15046732 |
MESH:D005909 |
Glioblastoma |
|
Ethylnitrosourea |
6.94 | 16436596 |
MESH:D005909 |
Glioblastoma |
|
Testosterone |
6.94 | 17162496 |
MESH:D005910 |
Glioma |
|
Ethylnitrosourea |
3.33 | 18412241 16651633 16357521 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.67 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.19 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.12 | 11294989 10048152 |
MESH:D006333 |
Heart Failure |
|
Dobutamine |
6.64 | 17440445 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.64 | 20558911 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.04 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.98 | 11000095 |
MESH:D006501 |
Hepatic Encephalopathy |
|
Thioacetamide |
4.22 | 18665440 17276928 15929193 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
25.38 | 6705139 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
25.38 | 19110552 19900420 |
MESH:D006505 |
Hepatitis |
|
Drugs, Chinese Herbal |
25.38 | 18339527 |
MESH:D006505 |
Hepatitis |
|
Thioacetamide |
25.38 | 16456712 |
MESH:D006505 |
Hepatitis |
|
Zymosan |
25.38 | 19110552 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
12.24 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
12.24 | 18467677 19176532 16221962 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
12.24 | 15340226 16120746 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.63 | 15709030 |
MESH:D006628 |
Hirsutism |
|
Testosterone |
5.25 | 17019078 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.35 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.64 | 15340226 18606429 8697196 16959395 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
7.21 | 18783367 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
7.21 | 12083418 |
MESH:D017588 |
Hyperandrogenism |
|
Testosterone |
4.91 | 17019078 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.14 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.24 | 21332399 |
MESH:D006943 |
Hyperglycemia |
marker/mechanism |
|
| 15093691 19682441 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.84 | 20558911 |
MESH:D006946 |
Hyperinsulinism |
marker/mechanism |
|
| 15093691 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.11 | 17050553 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.26 | 21332399 |
MESH:D006963 |
Hyperphagia |
marker/mechanism |
|
| 15093691 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.55 | 15034207 |
MESH:D006973 |
Hypertension |
|
Arsenic |
4.70 | 16076760 9931084 11953799 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.70 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.70 | 15338365 |
MESH:D006976 |
Hypertension, Pulmonary |
|
gefitinib |
4.41 | 18424623 |
MESH:D017380 |
Hypertrophy, Right Ventricular |
|
gefitinib |
5.84 | 18424623 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.16 | 16093927 |
MESH:D007006 |
Hypogonadism |
marker/mechanism |
|
| |
MESH:D007006 |
Hypogonadism |
|
Testosterone |
4.31 | 12002444 |
MESH:D007018 |
Hypopituitarism |
|
Testosterone |
5.80 | 17426086 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.42 | 16945680 16569931 |
MESH:D007174 |
Impulse Control Disorders |
|
Testosterone |
5.45 | 7506515 |
MESH:D007246 |
Infertility |
marker/mechanism |
|
| 15093691 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.10 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.23 | 17937319 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
20.98 | 20412841 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
20.98 | 18785209 |
MESH:D007249 |
Inflammation |
|
Fatty Acids, Omega-3 |
20.98 | 17296493 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
20.98 | 9205823 12878042 17963957 17237260 17255318 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
20.98 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
20.98 | 12878042 12200463 |
MESH:D007249 |
Inflammation |
|
Zymosan |
20.98 | 8014878 11289658 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
10.78 | 11836018 18457598 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
10.78 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
10.78 | 16306350 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.27 | 17255318 |
MESH:D043183 |
Irritable Bowel Syndrome |
|
Zymosan |
5.44 | 17553498 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.62 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
8.95 | 15513904 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
8.95 | 16580747 |
MESH:D007642 |
Keratosis |
|
Arsenic |
4.60 | 16930632 12749816 |
MESH:D007674 |
Kidney Diseases |
|
Chromium |
9.02 | 17934191 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
9.02 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Mercury |
9.02 | 17934191 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
24.98 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
24.98 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
24.98 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
24.98 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Ethylnitrosourea |
24.98 | 17379185 |
MESH:D007680 |
Kidney Neoplasms |
|
gefitinib |
24.98 | 18625569 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
4.64 | 16316344 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
3.83 | 15451040 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Drugs, Chinese Herbal |
3.75 | 15802533 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
3.29 | 17339181 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.30 | 15821434 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
4.83 | 8812269 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
3.53 | 17676605 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
18.38 | 11903743 16239168 16943688 17334410 11408273 17174718 17157831 21278145 16221502 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
18.38 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
18.38 | 20032147 18407596 18522880 19638242 18665156 |
MESH:D008103 |
Liver Cirrhosis |
|
Drugs, Chinese Herbal |
18.38 | 17163593 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
18.38 | 15289165 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
4.70 | 18295389 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
2.95 | 9327722 15034207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
12.21 | 18376398 18317297 17698563 16097048 14512876 16136751 18277467 18705752 16638106 15057751 18472094 16116963 17721639 18156304 15338365 14724832 15931870 18395095 17922224 12958196 18205269 15996030 15818738 15893842 12666154 15650968 18006644 11481614 15925388 14716833 12649538 18420326 17823541 17481882 18054572 14748882 10355542 12741479 16248980 18187930 18210741 12586293 18472332 20821823 14716496 15876570 18412020 17900296 12445418 18263696 17557913 12445421 15370692 17640975 15673190 17766677 12546737 16033810 16015684 12667390 17869086 18166357 12389079 15052691 17714472 13678700 15730626 16011737 12898905 17525996 18279442 17976157 17805973 18481824 17708605 12609069 18395914 17631135 12632514 16192424 18251166 12632512 14620537 18418968 17761835 15959796 15362042 17565644 18429990 17944888 16027843 15123356 18339082 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Drugs, Chinese Herbal |
12.21 | 17348192 15383259 15339415 18606216 17666798 18237412 15818738 18567088 15864749 16610055 18371158 15744066 15849816 12632512 17036385 15754396 17881167 15763062 15641146 17629604 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
12.21 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
12.21 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
12.21 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
12.21 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
12.21 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Thioacetamide |
12.21 | 11481614 17292413 15075984 18295389 15288473 17355460 17127702 18458672 12085344 17629604 15474484 16343077 12531686 11172339 15334695 18031379 18263696 15716488 17050028 15078482 12891558 18380797 16098781 16489207 18416461 16248980 10677585 15288472 18395095 15095483 15465738 16126171 11682029 15158331 12679928 15316131 16097051 18032466 14739098 18615449 18606216 15362042 12557150 16511523 12175628 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
11.32 | 11134558 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
11.32 | 15830285 17285989 15720792 16246199 16964402 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
11.32 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Drugs, Chinese Herbal |
11.32 | 17207593 |
MESH:D008107 |
Liver Diseases |
|
Thioacetamide |
11.32 | 15158337 16337175 18374380 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
4.27 | 17347304 17207112 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.78 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
8.67 | 16899240 14706259 |
MESH:D017114 |
Liver Failure, Acute |
|
Thioacetamide |
8.67 | 15633222 12479984 15313186 17276928 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
30.91 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
30.91 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
30.91 | 19389873 21295105 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
30.91 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
30.91 | 17602206 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
30.91 | 20137499 19073162 19294768 19090486 15885732 20492335 15175105 10737359 12771043 20583210 18754104 16942905 18648771 2422723 19254457 19256749 20452335 19996281 19638242 20501860 19426721 9163691 18644402 19833225 19690152 19255062 21278145 19551842 20101389 19642983 18977376 21071580 19499222 12112319 19812893 2862719 20434301 21047994 19850985 18978307 21167192 19427195 20118626 20405173 |
MESH:D008113 |
Liver Neoplasms |
|
Drugs, Chinese Herbal |
30.91 | 18339527 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
30.91 | 14757943 18709148 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
30.91 | 15890375 20007298 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
30.91 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
20.12 | 2876784 6135515 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
20.12 | 598648 1399818 6587162 3712494 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
20.12 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
20.12 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
20.12 | 18093689 18079962 18282651 16267830 18164116 19009564 19519916 18775883 2563599 21159647 17174075 19539802 3124819 18544905 9362446 18308698 19126423 17854601 17942915 16842330 19004024 18253720 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
20.12 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
Dobutamine |
4.44 | 19353679 |
MESH:D008171 |
Lung Diseases |
|
Dobutamine |
7.13 | 16638327 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
7.13 | 8266340 19066396 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
7.97 | 21114838 |
MESH:D055370 |
Lung Injury |
|
Ozone |
7.97 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
7.82 | 17306315 19168569 17976673 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
7.82 | 20970405 6695378 21163286 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Drugs, Chinese Herbal |
7.82 | 18339527 |
MESH:D008175 |
Lung Neoplasms |
|
Ethylnitrosourea |
7.82 | 6695378 16271038 17703301 16019985 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
7.82 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
7.82 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Ethylnitrosourea |
3.66 | 15790496 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Ethylnitrosourea |
4.66 | 15375218 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Drugs, Chinese Herbal |
12.32 | 14758024 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
12.32 | 16891317 11807958 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ethylnitrosourea |
12.32 | 10767621 10838139 18041768 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
gefitinib |
12.32 | 18375820 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.08 | 19453300 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
3.82 | 18411066 15451040 |
MESH:D008579 |
Meningioma |
|
Ethylnitrosourea |
5.58 | 17943659 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.70 | 10496685 |
MESH:D009102 |
Multiple Organ Failure |
|
Zymosan |
4.85 | 10890648 18160304 15259001 10479408 15213630 15241586 17724436 12130978 12879239 15834315 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.12 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
1.97 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
13.64 | 15371236 |
MESH:D017202 |
Myocardial Ischemia |
|
Dobutamine |
13.64 | 12447174 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
13.64 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.25 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.25 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
9.04 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
9.04 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
5.14 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
5.14 | 3581430 9029167 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
1.76 | 17405874 |
MESH:D009374 |
Neoplasms, Experimental |
|
Ethylnitrosourea |
4.02 | 16707424 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.34 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
8.22 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.22 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
6.51 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
6.51 | 16620997 |
MESH:D009442 |
Neurilemmoma |
|
Ethylnitrosourea |
5.02 | 17160924 16003739 16651423 |
MESH:D009447 |
Neuroblastoma |
|
Topotecan |
3.64 | 15176712 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.02 | 20387270 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.01 | 17056641 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.71 | 20387270 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
4.57 | 9802331 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
4.06 | 19632207 21332399 16723640 20132043 18457598 17217161 18674790 11836018 20518802 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.06 | 20558911 |
MESH:D009767 |
Obesity, Morbid |
marker/mechanism |
|
| |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
13.09 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
13.09 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
13.09 | 4026338 6482804 |
MESH:D009837 |
Oligodendroglioma |
|
Ethylnitrosourea |
5.58 | 17160924 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.62 | 3988306 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
3.54 | 17882678 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Drugs, Chinese Herbal |
4.62 | 16548355 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
4.50 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
4.50 | 19401270 |
MESH:D010146 |
Pain |
|
Morphine |
3.88 | 15275824 15215642 18699797 6776300 20225289 16273134 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
4.93 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
4.93 | 12384795 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.32 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.10 | 7296757 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.85 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
3.81 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
4.60 | 6392382 15371236 16905509 |
MESH:D010538 |
Peritonitis |
|
Ozone |
9.13 | 16369182 |
MESH:D010538 |
Peritonitis |
|
Zymosan |
9.13 | 15259001 18760300 19088179 15979727 17826846 11985352 18557954 18977430 19641140 14761945 17371808 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.07 | 6228378 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
9.79 | 11605937 12224865 |
MESH:D011014 |
Pneumonia |
|
Ozone |
9.79 | 18381685 18929643 18007984 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.18 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.22 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
8.36 | 17132714 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.36 | 11118676 11896295 11222880 11399792 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
9.69 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Testosterone |
9.69 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
2.93 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.93 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
gefitinib |
2.93 | 17914592 15651060 16685379 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
3.64 | 21343184 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.92 | 15861022 16919318 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Drugs, Chinese Herbal |
6.02 | 16987627 |
MESH:D011658 |
Pulmonary Fibrosis |
|
gefitinib |
6.02 | 18424623 |
MESH:D012003 |
Rectal Fistula |
|
Drugs, Chinese Herbal |
5.56 | 15043669 |
MESH:D015427 |
Reperfusion Injury |
|
Morphine |
6.22 | 19211983 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
6.22 | 19058328 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.47 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.46 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.08 | 3692021 |
MESH:D012221 |
Rhinitis, Allergic, Perennial |
|
Drugs, Chinese Herbal |
4.87 | 15015336 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
8.31 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
8.31 | 18551238 |
MESH:D012640 |
Seizures |
|
Ethanol |
8.31 | 9754883 |
MESH:D018805 |
Sepsis |
|
Zymosan |
4.33 | 11441115 |
MESH:D012735 |
Sexual Dysfunction, Physiological |
|
Testosterone |
5.80 | 16631401 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.64 | 19834688 17050553 18709164 17453740 16353154 17548696 15952646 6392382 16759981 16702368 17938729 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
5.06 | 17050553 15504454 17029826 19538983 17976673 16251483 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.06 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.54 | 16709447 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
3.34 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Drugs, Chinese Herbal |
3.34 | 18339527 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
3.34 | 18456281 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
6.78 | 9211565 17918041 17189318 11906479 9562338 16755016 |
MESH:D013276 |
Stomach Ulcer |
|
olive oil |
6.78 | 16252198 12498302 |
MESH:D013345 |
Subarachnoid Hemorrhage |
|
Drugs, Chinese Herbal |
5.36 | 17634840 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
3.91 | 9754883 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
3.82 | 15821434 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.26 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.82 | 15669648 |
MESH:D013953 |
Thymus Neoplasms |
|
Ethylnitrosourea |
4.77 | 15790496 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.50 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
10.42 | 1399818 6582329 6587162 7505956 3712494 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
10.42 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
gefitinib |
10.42 | 16940797 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.28 | 19048282 |
MESH:D016171 |
Torsades de Pointes |
|
Dobutamine |
4.96 | 19353679 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
10.56 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
10.56 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
10.56 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
10.56 | 17976673 19429237 11144890 17306315 19322015 15987713 18640142 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
10.67 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
10.67 | 10091137 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
2.93 | 14692618 |
MESH:D014605 |
Uveitis |
|
Zymosan |
5.00 | 11006244 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
4.34 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.19 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.19 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.85 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.41 | 16723640 |
MESH:D014947 |
Wounds and Injuries |
|
Drugs, Chinese Herbal |
4.22 | 16313111 |